title: Improvement in endothelium-dependent brachial artery flow-mediated vasodilation with low-density lipoprotein cholesterol levels <100 mg/dl.
abstract: To determine whether the current National Cholesterol Education Program cholesterol recommendations are consistent with beneficial endothelium-dependent vasodilation, we prospectively assessed endothelium-dependent brachial artery vasoreactivity in 50 patients with stable coronary artery disease. Our results showed that endothelial-dependent vasoreactivity was greater when low-density lipoprotein cholesterol was <100 mg/dl, suggesting that it may be beneficial to reach the National Cholesterol Education Program Adult Treatment Panel II target of low-density lipoprotein cholesterol of <100 mg/dl.
authors.affiliation: Department of Medicine, Cedars-Sinai Medical Center and the UCLA School of Medicine, Los Angeles, California 90048, USA. shechtes@netvision.net.il
authors.forename: M
authors.initials: M
authors.lastname: Shechter
authors.forename: M
authors.initials: M
authors.lastname: Sharir
authors.forename: M J
authors.initials: MJ
authors.lastname: Labrador
authors.forename: J
authors.initials: J
authors.lastname: Forrester
authors.forename: C N
authors.initials: CN
authors.lastname: Merz
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001783:Blood Flow Velocity / Q000502:physiology; D001916:Brachial Artery / Q000503:physiopathology*; D008078:Cholesterol, LDL / Q000097:blood*; D003327:Coronary Disease / Q000097:blood / Q000209:etiology / Q000503:physiopathology*; D018752:Diet, Fat-Restricted; D004730:Endothelium, Vascular / Q000503:physiopathology*; D005260:Female; D006801:Humans; D006937:Hypercholesterolemia / Q000097:blood / Q000150:complications / Q000503:physiopathology / Q000628:therapy; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D020127:Recovery of Function / Q000502:physiology*; D014664:Vasodilation / Q000502:physiology*
chemical_list: D008078:Cholesterol, LDL; D000960:Hypolipidemic Agents